A Use of AI (Artificial Intelligence) and Machine learning applications in Microbiology Ujjain (M.P) AI (Artificial Intelligence) and Machine learning
Main Article Content
Abstract
The integration of artificial intelligence (AI) and machine learning (ML) into the field of microbiology is making a significant impact on both research and clinical practices. These technologies are now play a important role to understand microbial systems, improve diagnostic accuracy, speed up drug discovery and tailor treatments to individual patients. The applications of AI in the field of microbiology include helping in genome sequencing, predicting antimicrobial resistance among pathogens, for developing vaccines and analyzing microbiomes. In industrial areas, AI is act as important tool in quality control and safety in the pharmaceutical, food, and cosmetic industries. However, despite these advancements, thereare still challenges that prevent us from fully realizing the potential of AI and ML in microbiology.
Although some issues such as inconsistent data quality, the complexity of algorithms that can be difficult to interpret, alack ofregulatoryguidelines and ethical concerns surrounding data privacy and algorithm bias must be addressed. There is a pressing need for collaboration across various fields, transparent development of models, and cooperation among academic institutions and healthcare providers globally. In the future, we can expect in novations indeeplearning, hybrid modeling techniques, andthe development of international standardsand policies to drive further advancements. With responsible implementation and ongoing research, AI and ML areset to become essential tools in microbiology, offering innovative solutions to persistent challenges in healthcare, diagnostics, and environmental monitoring. This review focuses on the current uses, challenges, and future directions of AI in microbiology, high lighting the importance of ethical considerations, collaboration and data-driven strategies to achieve meaningful and sustainable outcomes.
Keywords: Artificial intelligence, Global Health, Machine learning, Antimicrobial resistance, Personalized healthcare.
Article Details
Issue
Section
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
How to Cite
References
References
1.Mondal,R.S.,Akter,L.,Bhuiyan,M.N.A.(2025)."Integrating AI and ML techniques in modern microbiology", Applied IT & Engineering, 3(1),1-10,10323
2.Jiang,Y.,Luo,J.,Huang,D.,Liu,Y.,&Li,D.D.(2022).Machine learning advances in microbiology: A review of methods and applications. Frontiers in Microbiology, 13, 925454.
3.Mintz,Y.,&Brodie,R.(2019).Introduction to artificial intelligence in medicine.Minimally Invasive Therapy & Allied Technologies, 28(2), 73-81.
4.Kaul,V.,Enslin,S.,&Gross,S. A.(2020).History of artificial intelligence in medicine.Gastrointestinal endoscopy, 92(4), 807-812.
5.JordanM.I.,Mitchell T.M.(2015).Machine learning:trends, perspectives,and prospects.Science349,255– 260.
6.Domingos P.(2012).A few useful things to know about machin learning.Commun.ACM55,78–87.
7.Becht,E., McInnes, L.,Healy,J.,Dutertre,C.A.,Kwok,I.W.H.,Ng,L.G.,etal.(2018).Dimensionality reduction for visualizing single-cell data usingUMAP. Nat. Biotechnol. 37, 38–44. doi:10.1038/nbt.4314
8.Cammarota,G.,Ianiro,G.,Ahern, A.,Carbone,C.,Temko, A.,Claesson,M.J.,etal.(2020).Gut microbiome, big data,and machine learning to promote precision medicine for cancer.Nat.Rev.Gastroenterol.Hepatol.17, 635–648. doi: 10.1038/s41575-020-0327-3
9.Campbell, T. W., Wilson, M. P., Roder, H., MaWhinney, S., Georgantas, R. W., 3rd, Maguire, L. K., et al. (2021).Predicting prognosis in COVID-19 patients using machine learning and readily available clinical data. Int. J. Med. Inform. 155, 104594.
10.Cao, J., Xiao, Y., Zhang, M., Huang, L., Wang, Y., Liu, W., et al. (2023). Deep learning of dual plasma fingerprintsfor high-performanceinfectionclassification.Small19,e2206349.doi:10.1002/smll.202206349
11.Chen,X.,Ren,B.,Chen,M.,Wang,Q.,Zhang, L.,Yan,G.(2016).NLLSS:Predicting synergistic drug combinations based on semi-supervised learning. PloS Comput. Biol. 12, e1004975. Doi: 10.1371/journal.pcbi.1004975
12.David,J.A.,Zhichao, A.,Mark,A.,Chris,A.,Allcock, A.,Brian,A.,etal.(2022).A blood atlas of COVID-19 defines hallmarks of disease severity and specificity. Cell 185, 916– 938.e58.
13.DeFátima Cobre, A.,Surek,M.,Stremel,D.P.,Fachi,M. M.,LoboBorba,H.H.,Tonin,F.S., etal.(2022). Diagnosis and prognosis of COVID-19 employing analysis of patients’ plasma and serum via LC-MS and machine learning. Comput. Biol. Med.. 146, 105659.
14.Deo,R.C.(2015).Machine learning in medicine.Circulation132,1920–1930.doi: 10.1161/CIRCULATIONAHA.115.001593
15.Fabian,P.,Gaël,V.,Alexandre,G.,Vincent,M.,Bertrand,T.,Olivier,G.,etal.(2011).Scikitlearn:Machine Learning in Python. J. Mach. Learn. Res. 12, 2825–2830.
16.Gao,A.,Kouznetsova,V. L.,Tsigelny, I.F.(2022).Machine-learning-based virtual screening to repurpose drugs for the treatment of Candida albicans infection. Mycoses 65, 794–805. doi: 10.1111/myc.13475
17.Habgood-Coote, D., Wilson, C., Shimizu, C., Barendregt, A. M., Philipsen, R., Galassini, R., et al. (2023). Diagnosis of Childhood FebrileIllness Usinga Multiclass Blood RNA Molecular Signature.Med4,635–654.e5. doi: 10.1016/j.medj.2023.06.007
18.Kaufman,S.,Rosset, S.,Perlich,C., Stitelman,O.(2012).Leakageindata mining:Formulation, detection,and avoidance. ACM Trans. Knowl. Discovery Data 6, 1– 21. doi: 10.1145/2382577.2382579
19.Kaul,V.,Enslin,S.,Gross,S. A.(2020).History of artificial intelligence in medicine.Gastrointes tEndosc92, 807–812. doi: 10.1016/j.gie.2020.06.040
20.Shan,W.,Li,X.,Yao,H.,Lin,K.(2021).Convolutional neuralnetwork-basedvirtualscreening.Curr.Med. Chem. 28, 2033–2047. doi: 10.2174/0929867327666200526142958
21.Siddique,M.A.B.,Debnath,A.,Nath,N.D.,Biswash,M.A.R.,Tufael(2018)."Advancing Medical Science through Nanobiotechnology: Prospects, Applications, and Future Directions", Journal of Primeasia,
1.1(1),1-7,10163